Lenalidomide and Paclitaxel in Prostate Cancer

NCT00933426 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

17

Enrollment

OTHER

Sponsor class

Stopped Terminated early due to slow accrual as Phase I dose escalation study.

Conditions

Prostate Cancer

Interventions

DRUG: Lenalidomide
DRUG: Paclitaxel

Sponsor

M.D. Anderson Cancer Center

Collaborators

[object Object]